Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12624001151527Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial in edentulism comparing Amoxicillin with Placebo (2 arms). Primary endpoint: Early implant failure. Planned start Oct 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12624001151527.